Table 3 Susceptibility profile of the 16 strains resistant to at least 1 of the antimicrobial therapy evaluated
From: Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections
Patient | Surgical procedure | Strains | Ceftobiprole | Vancomycin–cefepime | Vancomycin-3rd generation cephalosporin | Vancomycin–piperacillin–tazobactam |
|---|---|---|---|---|---|---|
A | 1 | Yeast | R | R | R | R |
B | 1 | Yeast | R | R | R | R |
C | 1 | E. raffinosus | R | S | S | S |
2 | E. raffinosus | R | S | S | S | |
3 | ESBL-producing E. coli | R | R | R | S | |
D | 1 | ESBL-producing E. cloacae | R | R | R | R |
2 | ESBL-producing E. cloacae | R | R | R | R | |
E | 1 | E. coli | S | S | S | R |
F | 1 | K. pneumoniae | S | S | S | R |
G | 1 | ESBL-producing K. pneumoniae | R | R | R | R |
OXA23-producing A. baumannii | R | R | R | R | ||
H | 1 | ESBL-producing E. cloacae | R | R | R | R |
2 | P. aeruginosa | S | S | R | S | |
I | 1 | P. aeruginosa | R | S | R | S |
J | 1 | P. aeruginosa | S | S | R | S |
K | 1 | B. thetaiotaomicron | R | R | R | S |